Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lactoferrin in Treatment of Fe Deficient Anemia In Cirrhosis
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
Summary
Iron deficiency and altered homeostasis due to inflammation and decreased iron utilization are main factors involved in anemia in liver disease. Lactoferrin is a first line defence protein for protection against microbial infections and subsequent development of systemic disease as seen with systemic inflammatory response syndrome (SIRS) and sepsis. Lactoferrin with iron has been shown to be efficacious with anemia in chronic disease, in pregnancy and in cancer patients with fewer side effects than oral iron alone. High exposure to iron is associated with increased inflammation which is associated with worse cardiovascular outcomes. Lactoferrin can help reduce the total iron dose and hepatic inflammation.
Official title: Lactoferrin With Iron Versus Iron Alone in Treatment of Anemia In Chronic Liver Disease
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
130
Start Date
2020-01-01
Completion Date
2026-12
Last Updated
2026-11-13
Healthy Volunteers
Yes
Interventions
Lactoferrin + Iron Supplement
Lactoferrin 100 mg twice daily +oral iron
Iron Supplement
Oral iron supplement alone
Locations (1)
Postgraduate Institute of Medical Education and Research
Chandigarh, India